Effectiveness of Ritonavir-Boosted Protease Inhibitor Monotherapy in Clinical Practice Even with Previous Virological Failures to Protease Inhibitor-Based Regimens.

BACKGROUND AND OBJECTIVE:Significant controversy still exists about ritonavir-boosted protease inhibitor monotherapy (mtPI/rtv) as a simplification strategy that is used up to now to treat patients that have not experienced previous virological failure (VF) while on protease inhibitor (PI) -based re...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Luis F López-Cortés, Manuel A Castaño, Miguel A López-Ruz, María J Rios-Villegas, José Hernández-Quero, Dolores Merino, Patricia Jiménez-Aguilar, Manuel Marquez-Solero, Alberto Terrón-Pernía, Francisco Tellez-Pérez, Pompeyo Viciana, Francisco Orihuela-Cañadas, Zaira Palacios-Baena, David Vinuesa-Garcia, Jose M Fajardo-Pico, Alberto Romero-Palacios, Guillermo Ojeda-Burgos, Juan Pasquau-Liaño
Médium: Artigo
Jazyk:Inglês
Vydáno: Public Library of Science (PLoS) 2016-01-01
Edice:PLoS ONE
On-line přístup:http://europepmc.org/articles/PMC4752289?pdf=render
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky